Anti-Aging drug trial targets kidney disease frailty
NCT ID NCT02848131
First seen May 20, 2026 · Last updated May 20, 2026
Summary
This study tests whether removing aged, worn-out cells can improve physical frailty and stem cell health in 30 adults aged 40-80 with moderate-to-severe chronic kidney disease and diabetes. Participants receive a senolytic drug combination, and researchers measure changes in cell aging markers and physical function over 14 days. The goal is to understand if clearing these 'zombie cells' can reduce disease burden, not to cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.